Industry News
-
Scientists develop largest ever biological AI model that ‘thinks in nucleotides’
Feb 19 2025 -
Global Genes Awarded Prestigious $1.5 Million Technology Grant by the Chan Zuckerberg Initiative
Feb 18 2025 -
Biogen buys rights to Stoke’s rare epilepsy drug
Feb 18 2025 -
As NIH Cuts Loom, Research Organizations Need to Weigh Alternatives
Feb 14 2025 -
Roche’s Evrysdi becomes first pill Cleared for spinal muscular atrophy
Feb 13 2025 -
Phase 2 Trial for BMS’s Liso-Cel Meets Primary End Point in R/R Marginal Zone Lymphoma Cohort
Feb 12 2025 -
Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Feb 12 2025 -
NKGen’s Autologous NK Cell Therapy Troculeucel Fast Tracked for Alzheimer Disease
Feb 12 2025 -
Immix Biopharma’s CAR-T NXC-201 Snags FDA RMAT Designation for Light Chain Amyloidosis
Feb 10 2025